Skip to content
Talk to us
Talk to us

Briefings

What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.

Monitoring reports, cosmetic products

Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.

See what happens after launch →

210 items

Results

Monitoring report

Publication of form template to be used for product recalls

Topic: PUBLICATION OF FORM TEMPLATE TO BE USED FOR PRODUCT RECALLS

Date of publication: 23/07/2024

On May 27 2024, the European Commission published the Implementing Regulation (EU) 2024/1435, establishing a template for product recall notice. On July 23, 2024, the European Commission published a corrigendum adding an additional "whereas" and adapting the recall model accordingly. This regulation will be effective from December 13, 2024, aligning with the GPSR.

Monitoring report

CMR substances prohibited by Omnibus Act VII

Ingredients: DIMETHYLTOLYLAMINE, TRIMETHYLBENZOYL DIPHENYLPHOSPHINE OXIDE

Date of publication: 24/06/2024

On June 24, 2024, the European Commission (EC) notified to the World Trade Organization (WTO) the “Omnibus VII” regulation. The adoption is expected to take place after the September 1st, 2025.

Monitoring report

Amendment to European Cosmetics Regulation – New restrictions on cosmetic ingredients

Ingredients: 3-(4′-methylbenzylidene)-camphor; Genistein; Daidzein; Kojic Acid; Alpha-Arbutin; Arbutin; Retinol; Retinyl Acetate; Retinyl Palmitate

Date of publication: 04/04/2024

On April 4, 2024, the European Commission published Commission Regulation (EU) 2024/996, which brings new restrictions on several cosmetic ingredients.

Monitoring report

UK – Cosmetic Ingredients Added to the GB Mandatory Classification List

Topic: COSMETIC INGREDIENTS ADDED TO THE GB MANDATORY CLASSIFICATION LIST

Date of publication: 12/03/2024

On March 12, 2024, the Health and Safety Executive (HSE) added 25 chemical substances to the GB Mandatory Classification List (MCL). This introduces new mandatory classifications under Article 37 of the GB Classification, Labelling and Packaging (CLP) Regulation for these substances.

Monitoring report

Belgium Proposes Propylparaben to be classified as an Environmental Endocrine Disruptor Category 1 

Topic: BELGIUM PROPOSES PROPYLPARABEN TO BE CLASSIFIED AS AN ENVIRONMENTAL ENDOCRINE DISRUPTOR CATEGORY

Date of publication: 14/05/2024

On May 14, 2024, the European Chemicals Agency (ECHA) announced that Belgium plans to propose the harmonised classification and labelling of Propylparaben (Propyl 4-hydroxybenzoate, CAS no: 94-13-3, EC no:202-307-7) as an endocrine disruptor for the environment.

Monitoring report

UK introduces new packaging labelling for recycled materials 

Topic: UK INTRODUCES NEW PACKAGING LABELLING FOR RECYCLED MATERIALS

Date of publication: 01/05/2024

On May 1, 2024, the UK notified the World Trade Organization (WTO) about a draft regulation called The Producer Responsibility Obligations (Packaging and Packaging Waste) Regulations 2024. This draft includes provisions which require UK packaging producers to implement recycling labels. The draft is open for comments until June 30, 2024, and is expected to come into force on January 1, 2025.

Monitoring report

SCCS Preliminary Opinion on new coating for Titanium Dioxide (nano)

Ingredients: TITANIUM DIOXIDE (NANO)

Date of publication: 27/05/2024

On May 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on new coating for Titanium Dioxide (nano). The deadline for comments is set to July 22, 2024.

Monitoring report

New Restrictions to D4, D5 and D6 – REACH amendment

Topic: NEW RESTRICTIONS TO D4, D5 AND D6

Date of publication: 16/05/2024

On May 16, 2024, the European Commission published the Commission Regulation (EU) 2024/1328 which amended Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), adding restrictions to octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6).

Monitoring report

DECO Alert: Hair Care Packaging Resembling Children’s Fruit Pouches

Topic: DECO ALERT: HAIR CARE PACKAGING RESEMBLING CHILDREN'S FRUIT POUCHES Publication Date: 06/06/2024On June 6, 2024, the association DECO PROteste reported that the packaging of the new Fructis hair care range could be mistaken for children's fruit pouches and reminded that the law prohibits "dangerous imitations."

Cosmetic Products

Monitoring report

European Commission requests SCCS Opinion on the safety of Cyclamen Aldehyde

Ingredient: CYCLAMEN ALDEHYDE

Date of publication: 8 June 2026

The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.

Monitoring report

European Cosmetics Regulation – Updates on Cosmetic Ingredients  

Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS

Date of publication: 13 January 2026

The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).

Monitoring report

United Kingdom publishes Technical Report on the Classification and Labelling of Talc 

Ingredient: TALC

Date of publication: January 2026

The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.

Medical Devices

EU

How to demonstrate equivalence under the MDR

Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.

Follow an area

One email when an area publishes, in the language you choose. Nothing else.

Follow an area
Archive →